Integra Lifesciences Holdings
Integra LifeSciences Holdings Corporation is an American medical device manufacturer specializing in neurosurgery, regenerative tissue technologies, and surgical instrumentation. The company operates through two main business segments: Codman Specialty Surgical, manufacturing neurosurgical implants, dural repair membranes, and surgical instruments, and Tissue Technologies, producing regenerative skin and wound care matrixes under brands like MicroMatrix. Principal revenues derive from direct equipment sales of surgical devices, regenerative implants, and tissue matrixes to hospital surgical departments. Core end markets encompass neurosurgeons, plastic reconstructive surgeons, orthopedic wound specialists, and surgical hospitals globally. Integra LifeSciences holds a market-leading global position in neurosurgical dural grafts and regenerative tissue matrix products. The corporation is headquartered in Princeton, New Jersey, and its common stock trades on the Nasdaq Global Select Market.
4 of the funds FundTelligence covers report a position in Integra Lifesciences Holdings.
- Legal name
- INTEGRA LIFESCIENCES HOLDINGS
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 4
Funds holding Integra Lifesciences Holdings
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.09 % (full portfolio disclosed, October 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.07 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)
- Nordea Internationale aktier — Nordea Funds · 0.0 % (full portfolio disclosed, September 2026)